Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
GW PHARMACEUTICALS PLC (GWPH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 05/17/2021 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 05/07/2021 |
4
| Tovey Christopher J. (COO) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Disposed/sold 2,496 shares
@ $0
Disposed/sold 52,560 options to buy
@ $9.8117, valued at
$515.7k
Disposed/sold 6,468 options to buy
@ $0.0017, valued at
$11
Disposed/sold 58,884 options to buy
@ $9.6092, valued at
$565.8k
Disposed/sold 119,340 options to buy
@ $0.0017, valued at
$202.9
Disposed/sold 17,904 options to buy
@ $0.0017, valued at
$30.4
Disposed/sold 42,048 options to buy
@ $14.3342, valued at
$602.7k
Disposed/sold 79,812 options to buy
@ $0.0017, valued at
$135.7
Disposed/sold 17,964 options to buy
@ $0.0017, valued at
$30.5
Disposed/sold 137,016 options to buy
@ $0.0017, valued at
$232.9
Disposed/sold 82,224 options to buy
@ $0.0017, valued at
$139.8 |
|
| 05/07/2021 |
4
| Cline Darren S (U.S. Chief Commercial Officer) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Disposed/sold 5,556 shares
@ $0
Disposed/sold 54,192 options to buy
@ $15.3017, valued at
$829.2k
Disposed/sold 22,068 options to buy
@ $0.0017, valued at
$37.5
Disposed/sold 98,040 options to buy
@ $0.0017, valued at
$166.7
Disposed/sold 106,320 options to buy
@ $0.0017, valued at
$180.7
Disposed/sold 177,180 options to buy
@ $0.0017, valued at
$301.2
Disposed/sold 46,896 options to buy
@ $0.0017, valued at
$79.7
Disposed/sold 75,024 options to buy
@ $0.0017, valued at
$127.5 |
|
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2021 |
4
| Snyder Douglas B. (Chief Legal Officer) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Disposed/sold 61,848 shares
@ $0
Disposed/sold 82,956 options to buy
@ $8.3767, valued at
$694.9k
Disposed/sold 63,252 options to buy
@ $9.6092, valued at
$607.8k
Disposed/sold 46,644 options to buy
@ $14.3342, valued at
$668.6k
Disposed/sold 9,180 options to buy
@ $0.0017, valued at
$15.6
Disposed/sold 9,612 options to buy
@ $0.0017, valued at
$16.3
Disposed/sold 88,524 options to buy
@ $0.0017, valued at
$150.5
Disposed/sold 13,272 options to buy
@ $0.0017, valued at
$22.6
Disposed/sold 149,856 options to buy
@ $0.0017, valued at
$254.8
Disposed/sold 89,952 options to buy
@ $0.0017, valued at
$152.9
Disposed/sold 45,360 options to buy
@ $0.0017, valued at
$77.1 |
|
| 05/07/2021 |
4
| Gover Justin D. (CEO) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Disposed/sold 222,773 shares
@ $0
Disposed/sold 456,048 shares
@ $0
Disposed/sold 1,867,308 shares
@ $0
Disposed/sold 17,508 options to buy
@ $0.0017, valued at
$29.8
Disposed/sold 75,864 options to buy
@ $10.605, valued at
$804.5k
Disposed/sold 213,240 options to buy
@ $3.72, valued at
$793.3k
Disposed/sold 142,344 options to buy
@ $9.8117, valued at
$1.4M
Disposed/sold 147,624 options to buy
@ $9.6092, valued at
$1.4M
Disposed/sold 119,472 options to buy
@ $14.3342, valued at
$1.7M
Disposed/sold 30,936 options to buy
@ $14.645, valued at
$453.1k
Disposed/sold 22,440 options to buy
@ $0.0017, valued at
$38.1 |
|
| 05/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/07/2021 |
4
| MACKEY CATHERINE J (Director) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Disposed/sold 10,536 shares
@ $0
Disposed/sold 35,340 options to buy
@ $11.1742, valued at
$394.9k
Disposed/sold 16,548 options to buy
@ $14.3342, valued at
$237.2k
Disposed/sold 3,144 options to buy
@ $0.0017, valued at
$5.3
Disposed/sold 34,416 options to buy
@ $0.0017, valued at
$58.5
Disposed/sold 22,464 options to buy
@ $0.0017, valued at
$38.2 |
|
| 05/07/2021 |
4
| Knappertz Volker (Chief Medical Officer) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Disposed/sold 92,412 shares
@ $0
Disposed/sold 150,444 options to buy
@ $8.6433, valued at
$1.3M
Disposed/sold 55,536 options to buy
@ $9.6092, valued at
$533.7k
Disposed/sold 48,252 options to buy
@ $14.3342, valued at
$691.7k
Disposed/sold 12,156 options to buy
@ $0.0017, valued at
$20.7
Disposed/sold 8,436 options to buy
@ $0.0017, valued at
$14.3
Disposed/sold 91,584 options to buy
@ $0.0017, valued at
$155.7
Disposed/sold 13,728 options to buy
@ $0.0017, valued at
$23.3
Disposed/sold 155,028 options to buy
@ $0.0017, valued at
$263.5
Disposed/sold 93,024 options to buy
@ $0.0017, valued at
$158.1
Disposed/sold 47,808 options to buy
@ $0.0017, valued at
$81.3 |
|
| 05/07/2021 |
4
| GUY GEOFFREY W DR (Executive Chairman) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Disposed/sold 4,781,521 shares
@ $0
Disposed/sold 25,000 shares
@ $0
Disposed/sold 103,925 shares
@ $0
Disposed/sold 138,672 options to buy
@ $8.3767, valued at
$1.2M
Disposed/sold 15,336 options to buy
@ $0.0017, valued at
$26.1
Disposed/sold 107,352 options to buy
@ $9.6092, valued at
$1M
Disposed/sold 217,572 options to buy
@ $0.0017, valued at
$369.9
Disposed/sold 32,616 options to buy
@ $0.0017, valued at
$55.4
Disposed/sold 75,252 options to buy
@ $14.3342, valued at
$1.1M
Disposed/sold 142,824 options to buy
@ $0.0017, valued at
$242.8
Disposed/sold 32,112 options to buy
@ $0.0017, valued at
$54.6 |
|
| 05/07/2021 |
4
| Secor Alicia (Director) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Disposed/sold 10,584 shares
@ $0
Disposed/sold 35,340 options to buy
@ $11.1742, valued at
$394.9k
Disposed/sold 16,548 options to buy
@ $14.3342, valued at
$237.2k
Disposed/sold 3,144 options to buy
@ $0.0017, valued at
$5.3
Disposed/sold 34,416 options to buy
@ $0.0017, valued at
$58.5
Disposed/sold 22,464 options to buy
@ $0.0017, valued at
$38.2 |
|
| 05/07/2021 |
4
| Giacobello Scott M. (CFO) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Disposed/sold 165,108 shares
@ $0
Disposed/sold 67,164 options to buy
@ $8.6433, valued at
$580.5k
Disposed/sold 68,460 options to buy
@ $9.6092, valued at
$657.8k
Disposed/sold 44,184 options to buy
@ $14.3342, valued at
$633.3k
Disposed/sold 8,136 options to buy
@ $0.0017, valued at
$13.8
Disposed/sold 10,404 options to buy
@ $0.0017, valued at
$17.7
Disposed/sold 83,844 options to buy
@ $0.0017, valued at
$142.5
Disposed/sold 12,576 options to buy
@ $0.0017, valued at
$21.4
Disposed/sold 144,828 options to buy
@ $0.0017, valued at
$246.2
Disposed/sold 86,928 options to buy
@ $0.0017, valued at
$147.8
Disposed/sold 43,824 options to buy
@ $0.0017, valued at
$74.5 |
|
| 05/07/2021 |
4
| Brown Cabot (Director) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Disposed/sold 7,200 shares
@ $0
Disposed/sold 9,168 options to buy
@ $0.0017, valued at
$15.6
Disposed/sold 34,056 options to buy
@ $5.6992, valued at
$194.1k
Disposed/sold 18,636 options to buy
@ $9.8117, valued at
$182.9k
Disposed/sold 17,676 options to buy
@ $11.1742, valued at
$197.5k
Disposed/sold 16,548 options to buy
@ $14.3342, valued at
$237.2k
Disposed/sold 3,144 options to buy
@ $0.0017, valued at
$5.3
Disposed/sold 34,416 options to buy
@ $0.0017, valued at
$58.5
Disposed/sold 22,464 options to buy
@ $0.0017, valued at
$38.2 |
|
| 05/07/2021 |
4
| Waldegrave William A. (Director) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Disposed/sold 35,340 options to buy
@ $11.1742, valued at
$394.9k
Disposed/sold 7,164 options to buy
@ $0.0017, valued at
$12.2
Disposed/sold 16,548 options to buy
@ $14.3342, valued at
$237.2k
Disposed/sold 9,432 options to buy
@ $0.0017, valued at
$16
Disposed/sold 34,416 options to buy
@ $0.0017, valued at
$58.5
Disposed/sold 22,464 options to buy
@ $0.0017, valued at
$38.2 |
|
| 05/05/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/05/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/05/2021 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 05/05/2021 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
| 05/05/2021 |
8-K
| Quarterly results |
| 05/05/2021 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 04/30/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
| 04/30/2021 |
10-K/A
| Annual Report for the period ended December 31, 2020 [amend] |
| 04/28/2021 |
GN
| GW Pharmaceuticals recognised for leadership in prescription cannabis-based medicines with prestigious Queen's Award for Enterprise in Innovation |
| 04/23/2021 |
8-K
| Quarterly results |
| 04/23/2021 |
GN
| GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals |
| 04/20/2021 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/20/2021 |
8-K
| Quarterly results |
| 04/20/2021 |
DFAN14A
| Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material: |
| 04/20/2021 |
GN
| GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures associated with tuberous sclerosis complex |
| 04/14/2021 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/14/2021 |
8-K
| Quarterly results |
| 04/08/2021 |
4
| Snyder Douglas B. (Chief Legal Officer) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Sold 8,400 shares
@ $18.12, valued at
$152.2k
|
|
| 03/30/2021 |
4
| Knappertz Volker (Director) has filed a Form 4 on GW PHARMACEUTICALS PLC|
Txns:
| Sold 3,060 shares
@ $18.1, valued at
$55.4k
|
|
|
|
|